Differential regulation of mRNA fate by the human Ccr4-Not complex is driven by coding sequence composition and mRNA localization.


Journal

Genome biology
ISSN: 1474-760X
Titre abrégé: Genome Biol
Pays: England
ID NLM: 100960660

Informations de publication

Date de publication:
06 10 2021
Historique:
received: 29 10 2020
accepted: 10 09 2021
entrez: 7 10 2021
pubmed: 8 10 2021
medline: 29 1 2022
Statut: epublish

Résumé

Regulation of protein output at the level of translation allows for a rapid adaptation to dynamic changes to the cell's requirements. This precise control of gene expression is achieved by complex and interlinked biochemical processes that modulate both the protein synthesis rate and stability of each individual mRNA. A major factor coordinating this regulation is the Ccr4-Not complex. Despite playing a role in most stages of the mRNA life cycle, no attempt has been made to take a global integrated view of how the Ccr4-Not complex affects gene expression. This study has taken a comprehensive approach to investigate post-transcriptional regulation mediated by the Ccr4-Not complex assessing steady-state mRNA levels, ribosome position, mRNA stability, and protein production transcriptome-wide. Depletion of the scaffold protein CNOT1 results in a global upregulation of mRNA stability and the preferential stabilization of mRNAs enriched for G/C-ending codons. We also uncover that mRNAs targeted to the ER for their translation have reduced translational efficiency when CNOT1 is depleted, specifically downstream of the signal sequence cleavage site. In contrast, translationally upregulated mRNAs are normally localized in p-bodies, contain disorder-promoting amino acids, and encode nuclear localized proteins. Finally, we identify ribosome pause sites that are resolved or induced by the depletion of CNOT1. We define the key mRNA features that determine how the human Ccr4-Not complex differentially regulates mRNA fate and protein synthesis through a mechanism linked to codon composition, amino acid usage, and mRNA localization.

Sections du résumé

BACKGROUND
Regulation of protein output at the level of translation allows for a rapid adaptation to dynamic changes to the cell's requirements. This precise control of gene expression is achieved by complex and interlinked biochemical processes that modulate both the protein synthesis rate and stability of each individual mRNA. A major factor coordinating this regulation is the Ccr4-Not complex. Despite playing a role in most stages of the mRNA life cycle, no attempt has been made to take a global integrated view of how the Ccr4-Not complex affects gene expression.
RESULTS
This study has taken a comprehensive approach to investigate post-transcriptional regulation mediated by the Ccr4-Not complex assessing steady-state mRNA levels, ribosome position, mRNA stability, and protein production transcriptome-wide. Depletion of the scaffold protein CNOT1 results in a global upregulation of mRNA stability and the preferential stabilization of mRNAs enriched for G/C-ending codons. We also uncover that mRNAs targeted to the ER for their translation have reduced translational efficiency when CNOT1 is depleted, specifically downstream of the signal sequence cleavage site. In contrast, translationally upregulated mRNAs are normally localized in p-bodies, contain disorder-promoting amino acids, and encode nuclear localized proteins. Finally, we identify ribosome pause sites that are resolved or induced by the depletion of CNOT1.
CONCLUSIONS
We define the key mRNA features that determine how the human Ccr4-Not complex differentially regulates mRNA fate and protein synthesis through a mechanism linked to codon composition, amino acid usage, and mRNA localization.

Identifiants

pubmed: 34615539
doi: 10.1186/s13059-021-02494-w
pii: 10.1186/s13059-021-02494-w
pmc: PMC8496106
doi:

Substances chimiques

CNOT1 protein, human 0
Codon 0
Nuclear Proteins 0
RNA, Messenger 0
Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

284

Subventions

Organisme : Cancer Research UK
ID : C596/A17196
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A31287
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/N017005/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A29252
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A600_1024
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M001865/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_G0902052
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s).

Références

Mol Biol Cell. 2015 Jul 15;26(14):2579-95
pubmed: 25995375
Cell. 2014 Sep 11;158(6):1238-1239
pubmed: 25215483
Biochem J. 2009 Aug 27;422(3):443-53
pubmed: 19558367
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Bioinformatics. 2012 Dec 1;28(23):3150-2
pubmed: 23060610
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1104-9
pubmed: 22232654
J Cell Sci. 2013 Sep 15;126(Pt 18):4274-85
pubmed: 23843623
Science. 2012 Apr 13;336(6078):237-40
pubmed: 22499947
Mol Biol Cell. 2015 May 15;26(10):1797-810
pubmed: 25808495
Cell. 2005 Sep 23;122(6):875-86
pubmed: 16179257
RNA. 2014 Aug;20(8):1298-319
pubmed: 24942623
Crit Rev Biochem Mol Biol. 2012 Jul-Aug;47(4):315-33
pubmed: 22416820
Mol Biol Cell. 2009 May;20(9):2464-72
pubmed: 19297524
PLoS One. 2011 Mar 28;6(3):e18302
pubmed: 21464899
Biochem Biophys Res Commun. 2009 Feb 27;380(1):28-32
pubmed: 19138671
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Mol Microbiol. 2012 Feb;83(3):640-53
pubmed: 22243599
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Science. 2012 Apr 13;336(6078):233-7
pubmed: 22422859
Genome Biol. 2014 Jan 13;15(1):R15
pubmed: 24417896
Nat Protoc. 2012 Jul 26;7(8):1534-50
pubmed: 22836135
Mol Cell. 2018 Jun 21;70(6):1081-1088.e5
pubmed: 29932901
EMBO Rep. 2019 Nov 5;20(11):e48220
pubmed: 31482640
Biochemistry. 2018 May 1;57(17):2424-2431
pubmed: 29381060
Prog Nucleic Acid Res Mol Biol. 2003;73:221-50
pubmed: 12882519
Mol Cell. 2020 Aug 6;79(3):459-471.e4
pubmed: 32553192
Nucleic Acids Res. 2011 May;39(10):4373-86
pubmed: 21278420
Mol Cell Biol. 2010 Mar;30(6):1486-94
pubmed: 20065043
Mol Cell. 2012 Oct 26;48(2):207-18
pubmed: 22959269
Genome Biol. 2014;15(12):550
pubmed: 25516281
Genes Dev. 1991 Nov;5(11):2108-16
pubmed: 1682219
Nucleic Acids Res. 2000 Feb 1;28(3):809-17
pubmed: 10637334
RNA. 2005 Nov;11(11):1640-7
pubmed: 16177138
Science. 2013 Apr 5;340(6128):82-5
pubmed: 23559250
Mol Cell. 2018 Dec 6;72(5):805-812
pubmed: 30526871
Cell. 2014 Sep 11;158(6):1281-1292
pubmed: 25215487
Bioinformatics. 2019 Jun 1;35(12):2084-2092
pubmed: 30395178
Nucleic Acids Res. 2020 Feb 28;48(4):1843-1871
pubmed: 31863588
J Biol Chem. 2010 Sep 10;285(37):28506-13
pubmed: 20634287
Genes Dev. 2011 Mar 15;25(6):581-93
pubmed: 21406554
Nat Struct Mol Biol. 2019 Feb;26(2):110-120
pubmed: 30692646
RNA. 2018 Oct;24(10):1377-1389
pubmed: 29997263
RNA. 2019 Dec;25(12):1751-1764
pubmed: 31527111
Mol Cell. 2009 Sep 24;35(6):868-80
pubmed: 19716330
Protein Cell. 2011 Sep;2(9):755-63
pubmed: 21976065
Nat Commun. 2019 Jan 18;10(1):331
pubmed: 30659192
J Cell Biol. 1989 Dec;109(6 Pt 1):2617-22
pubmed: 2556403
Mol Cell Biol. 1995 Apr;15(4):2219-30
pubmed: 7891716
Mol Cell. 2018 Oct 4;72(1):10-17
pubmed: 30290147
BMC Bioinformatics. 2006 Mar 09;7:123
pubmed: 16526949
Mol Cell. 2007 Mar 9;25(5):635-46
pubmed: 17349952
Genome Biol. 2021 Oct 6;22(1):284
pubmed: 34615539
Curr Genet. 2017 Aug;63(4):613-620
pubmed: 28028558
J Mol Biol. 2006 Jun 16;359(4):1137-49
pubmed: 16697407
J Biol Chem. 2012 Oct 19;287(43):36370-83
pubmed: 22955276
Nat Commun. 2016 Jan 25;7:10433
pubmed: 26804377
Dis Model Mech. 2020 Jul 20;13(7):
pubmed: 32471864
Cell. 2015 Mar 12;160(6):1111-24
pubmed: 25768907
Mol Cell. 2014 Jun 5;54(5):751-65
pubmed: 24768538
Proteomics. 2009 Jan;9(1):205-9
pubmed: 19053139
Wiley Interdiscip Rev RNA. 2019 Jan;10(1):e1508
pubmed: 30276972
Intrinsically Disord Proteins. 2013 Apr 1;1(1):e24684
pubmed: 28516010
Genome Biol. 2019 Jun 7;20(1):119
pubmed: 31174582
Cell Rep. 2018 Aug 14;24(7):1704-1712
pubmed: 30110627
Elife. 2018 Mar 15;7:
pubmed: 29543155
Genome Biol. 2019 Dec 2;20(1):262
pubmed: 31791371
Front Genet. 2019 May 02;10:332
pubmed: 31118942
Elife. 2019 Dec 19;8:
pubmed: 31855182
Mol Cell. 2011 Oct 7;44(1):120-33
pubmed: 21981923
Mol Cell. 2018 Jun 21;70(6):1089-1100.e8
pubmed: 29932902
RNA. 2010 Jul;16(7):1356-70
pubmed: 20504953
Biochem J. 2012 Jan 1;441(1):119-29
pubmed: 21883093
Gene. 2012 Jan 15;492(1):42-53
pubmed: 22027279
Nat Biotechnol. 2019 Apr;37(4):420-423
pubmed: 30778233
RNA. 2017 Nov;23(11):1636-1647
pubmed: 28768715
Genetics. 2001 Jun;158(2):627-34
pubmed: 11404327
Elife. 2019 Jan 02;8:
pubmed: 30601114
RNA Biol. 2013 Feb;10(2):228-44
pubmed: 23303381
Mol Cell. 2015 Sep 3;59(5):744-54
pubmed: 26321254
Nat Rev Mol Cell Biol. 2018 Mar;19(3):158-174
pubmed: 29165424
Genetics. 2000 Jul;155(3):1045-54
pubmed: 10880468
PLoS Comput Biol. 2017 Apr 14;13(4):e1005460
pubmed: 28410363
Methods Enzymol. 2010;470:119-42
pubmed: 20946809
Nucleic Acids Res. 2019 Sep 5;47(15):8224-8238
pubmed: 31180491
EMBO J. 2016 Jun 1;35(11):1186-203
pubmed: 27009120
Mol Cell. 1998 Jul;2(1):135-40
pubmed: 9702200
Front Genet. 2014 May 26;5:143
pubmed: 24904643
Genes Cells. 2005 May;10(5):455-64
pubmed: 15836774
Biochem Soc Trans. 2015 Dec;43(6):1253-8
pubmed: 26614669
Biochimie. 2020 Jul;174:49-56
pubmed: 32311426
BMC Genomics. 2017 May 10;18(1):364
pubmed: 28486986
Mol Cell. 2016 Mar 17;61(6):874-85
pubmed: 26990990
Genes Dev. 2005 Jan 1;19(1):104-13
pubmed: 15630022
Elife. 2019 Apr 23;8:
pubmed: 31012849
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Front Mol Biosci. 2017 Sep 29;4:67
pubmed: 29034245
Nat Struct Mol Biol. 2011 Oct 07;18(11):1218-26
pubmed: 21984184
J Cell Biol. 2008 Jul 14;182(1):89-101
pubmed: 18625844
Genome Biol. 2020 Feb 27;21(1):44
pubmed: 32102681
EMBO J. 2010 Aug 4;29(15):2566-76
pubmed: 20628353
PLoS One. 2009 Aug 27;4(8):e6783
pubmed: 19710908
Wiley Interdiscip Rev RNA. 2011 Mar-Apr;2(2):167-83
pubmed: 21957004
Nucleic Acids Res. 2019 Jan 8;47(D1):D766-D773
pubmed: 30357393
Mol Cell Biol. 2010 Sep;30(17):4308-23
pubmed: 20584987
Nature. 2008 Jun 26;453(7199):1276-80
pubmed: 18496529
Genes Dev. 2006 Jul 15;20(14):1885-98
pubmed: 16815998
Nat Rev Mol Cell Biol. 2018 Jan;19(1):20-30
pubmed: 29018283
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15023-15032
pubmed: 31292258
Wiley Interdiscip Rev RNA. 2016 Jul;7(4):438-54
pubmed: 26821858
Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4034-9
pubmed: 16495412
Transcription. 2011 May;2(3):103-108
pubmed: 21922053
Front Genet. 2014 May 16;5:137
pubmed: 24904637
J Biol Chem. 2009 Apr 17;284(16):10343-52
pubmed: 19204001
Am J Hum Genet. 2020 Jul 2;107(1):164-172
pubmed: 32553196
Genome Res. 2020 Jul;30(7):985-999
pubmed: 32703885
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Science. 2005 Oct 21;310(5747):486-9
pubmed: 16141371
PLoS Biol. 2013;11(3):e1001508
pubmed: 23554576
Nucleic Acids Res. 2019 Mar 18;47(5):2216-2228
pubmed: 30698781
EMBO J. 1998 Feb 16;17(4):1096-106
pubmed: 9463387
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W281-7
pubmed: 22638583
Cell. 2001 Feb 9;104(3):377-86
pubmed: 11239395
Genome Res. 2003 Sep;13(9):2129-41
pubmed: 12952881
Science. 2020 Apr 17;368(6488):
pubmed: 32299921
Mol Cell. 2017 Oct 5;68(1):144-157.e5
pubmed: 28965817
Biochem Soc Trans. 2012 Aug;40(4):896-901
pubmed: 22817755
PLoS One. 2020 Feb 13;15(2):e0228730
pubmed: 32053646
Biochim Biophys Acta. 2013 Jun-Jul;1829(6-7):561-70
pubmed: 23337855
Proc Natl Acad Sci U S A. 2018 May 22;115(21):E4940-E4949
pubmed: 29735666
Cell Rep. 2015 Oct 27;13(4):703-711
pubmed: 26489469
Gene. 2003 Aug 14;313:1-16
pubmed: 12957374
Genes Dev. 2020 Jun 1;34(11-12):847-860
pubmed: 32354837

Auteurs

Sarah L Gillen (SL)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
MRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.

Chiara Giacomelli (C)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.

Kelly Hodge (K)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.

Sara Zanivan (S)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.

Martin Bushell (M)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. martin.bushell@glasgow.ac.uk.
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. martin.bushell@glasgow.ac.uk.

Ania Wilczynska (A)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. awilcz@gmail.com.
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. awilcz@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH